Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Screening for Atrial Fibrillation, After Ischemic Stroke
Clinical trial update indicating the completion of a study on screening for atrial fibrillation after ischemic stroke.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Esophagus Imaging for Radiofrequency Ablation of Atrial Fibrillation [NA]
This trial update indicates the completion of a study evaluating esophagus imaging during radiofrequency ablation for atrial fibrillation.
-
CLINICAL_TRIALS research · 2011-06-22Clinical Trial Update: Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation [Phase 3]
This is a Phase 3 randomized trial evaluating whether polyunsaturated fatty acids (PUFA) help maintain sinus rhythm in patients with persist…
-
FDA approval · 2011-06-21FDA Approved: MULTAQ — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for MULTAQ (dronedarone) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS research · 2011-06-20Clinical Trial Update: Education Program for Patients Receiving Oral Anticoagulation [NA]
This clinical trial update describes an education program designed for patients receiving oral anticoagulation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: EvaluAtion of Predictive Value of Multisite Intracardiac EchoCardiography During Imaging of Structure and funCTION of Left Atrial Appendage in Comparison to Transesophageal Echocardiography [Phase 4]
A phase 4 clinical trial update evaluating whether multisite intracardiac echocardiography can predict the structure and function of the lef…
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm [Phase 3]
A Phase 3 trial compared amiodarone, sotalol, and placebo for maintaining sinus rhythm after conversion from atrial fibrillation. The study …
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Clinical Investigation of Wireless Transmission of Invasive Blood Pressure Signal
A completed clinical investigation explored wireless transmission of invasive blood pressure signals, highlighting feasibility of the techno…
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Left Atrial Distensibility to Predict Left Ventricular Filling Pressure and Prognosis in Patients With Severe Mitral Regurgitation
A completed clinical study evaluates whether left atrial distensibility can predict left ventricular filling pressures and prognosis in pati…
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Study of the Effect of Exercise Training on Patients in Atrial Fibrillation [NA]
This clinical trial evaluated the effects of structured exercise training on patients with atrial fibrillation; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Effects of Intravenous K201 on the Restoration of Sinus Rhythm in Subjects With Symptomatic Atrial Fibrillation [Phase 2]
A Phase 2 trial evaluating intravenous K201 for restoration of sinus rhythm in subjects with symptomatic atrial fibrillation was terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Phase 2 Study of Oral K201 for Prevention of AF Recurrence [Phase 2]
This update reports termination of a Phase 2 study evaluating oral K201 for prevention of atrial fibrillation recurrence.
-
CLINICAL_TRIALS research · 2011-05-11Clinical Trial Update: Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study [Phase 1, Phase 2]
Clinical trial update for the ICE-CHIP study in atrial fibrillation, reporting completion of Phase 1 and Phase 2.
-
FDA approval · 2011-04-28FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Sotalol Hydrochloride by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Safer Warfarin Treatment
A clinical trial evaluating safer warfarin treatment for conditions including atrial fibrillation and venous thromboembolism has been suspen…
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Predictive Genetic Risk Assessment Trial
This Mayo Clinic-sponsored trial on Predictive Genetic Risk Assessment has completed, investigating genetic risk prediction across multiple …
-
CLINICAL_TRIALS trial_result · 2011-04-25Clinical Trial Update: Catheter Ablation Versus Antiarrythmic Drugs for Atrial Fibrillation in China [Phase 4]
Phase 4 clinical trial update comparing catheter ablation versus antiarrhythmic drugs for atrial fibrillation in China; status information i…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: Prophylactic Pulmonary Vein Isolation Study [NA]
A Mayo Clinic-sponsored trial evaluating prophylactic pulmonary vein isolation for atrial fibrillation has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS) [Phase 3]
Phase 3 AMADEUS trial comparing SR34006 against warfarin or acenocoumarol in patients with atrial fibrillation has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-05Clinical Trial Update: Cytochrome P450 2D6 (CYP 450 2D6) Genotype and Flecainide Efficacy
An update on a clinical trial evaluating whether CYP2D6 genotype affects the efficacy of flecainide for atrial fibrillation.
-
FDA approval · 2011-03-11FDA Approved: MULTAQ — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved the supplemental application for Multaq (dronedarone) filed by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: A Randomized Study to Demonstrate the Safety and Feasibility of Plexisyl-AF in Patients Undergoing Coronary Artery Bypass Grafting (CABG) [NA]
Completed randomized trial evaluating the safety and feasibility of Plexisyl-AF in patients undergoing coronary artery bypass grafting who h…
-
CLINICAL_TRIALS research · 2011-03-08Clinical Trial Update: Left Atrial Distensibility to Predict Prognosis in Consecutive Patients
A clinical trial update examining whether left atrial distensibility can predict prognosis in patients with heart failure and atrial fibrill…
-
CLINICAL_TRIALS withdrawal · 2011-02-21Clinical Trial Update: AtriCure Bipolar Radiofrequency Ablation of Persistent Atrial Fibrillation [Phase 3]
A Phase 3 trial evaluating AtriCure's bipolar radiofrequency ablation for persistent atrial fibrillation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-02-21Clinical Trial Update: AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB [Phase 2]
A Phase 2 trial evaluating AtriCure's minimally invasive surgical ablation for atrial fibrillation (RESTORE IIB) has been withdrawn.